BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 10561341)

  • 1. Paclitaxel and cisplatin as first-line therapy in recurrent or advanced squamous cell carcinoma of the cervix: a gynecologic oncology group study.
    Rose PG; Blessing JA; Gershenson DM; McGehee R
    J Clin Oncol; 1999 Sep; 17(9):2676-80. PubMed ID: 10561341
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The platinum compounds and paclitaxel in the management of carcinomas of the endometrium and uterine cervix.
    Thigpen T; Vance RB; Khansur T
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):67-75. PubMed ID: 7481864
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Randomized trial of cisplatin versus cisplatin plus mitolactol versus cisplatin plus ifosfamide in advanced squamous carcinoma of the cervix: a Gynecologic Oncology Group study.
    Omura GA; Blessing JA; Vaccarello L; Berman ML; Clarke-Pearson DL; Mutch DG; Anderson B
    J Clin Oncol; 1997 Jan; 15(1):165-71. PubMed ID: 8996138
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phase II trial of biweekly paclitaxel and cisplatin in advanced breast carcinoma: an Eastern Cooperative Oncology Group study.
    Sparano JA; Neuberg D; Glick JH; Robert NJ; Goldstein LJ; Sledge GW; Wood W
    J Clin Oncol; 1997 May; 15(5):1880-4. PubMed ID: 9164198
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phase I/II study of paclitaxel plus cisplatin as first-line chemotherapy for advanced non-small cell lung cancer: preliminary results.
    Belli L; LeChevalier T; Gottfried M; Adams D; Ruffie P; LeCesne A; Tete L; Pellae-Cosset B
    Semin Oncol; 1995 Dec; 22(6 Suppl 15):29-33. PubMed ID: 8643967
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Carboplatin plus paclitaxel as first-line chemotherapy in previously untreated advanced ovarian cancer. German AGO Study Group Ovarian Cancer. Arbeitsgemeinschaft Gynäkologische Onkologie.
    du Bois A; Lück HJ; Meier W; Möbus V; Costa S; Richter B; Bauknecht T; Warm M; Schroeder W; Olbricht S; Nitz U; Jackisch C
    Semin Oncol; 1997 Aug; 24(4 Suppl 11):S11-28-S11-33. PubMed ID: 9314296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-escalated paclitaxel in 1-hour infusion with a fixed dose of cisplatin in previously untreated advanced ovarian cancer: a phase II trial of the Spanish Group for Ovarian Cancer.
    Cervantes A; Mendiola C; del Campo JM; Massuti B; Casado A; Escobedo A; Moyano A; Ojeda B; Poveda A; Benito D
    Semin Oncol; 1997 Oct; 24(5 Suppl 15):S15-40-S15-43. PubMed ID: 9346221
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Paclitaxel, cisplatin, and 5-fluorouracil in patients with advanced or recurrent squamous cell carcinoma of the head and neck: a preliminary report.
    Hussain M; Salwen W; Kucuk O; Ensley J
    Semin Oncol; 1997 Dec; 24(6 Suppl 19):S19-43-S19-45. PubMed ID: 9427265
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase II randomized trial of cisplatin chemotherapy regimens in the treatment of recurrent or metastatic squamous cell cancer of the cervix: a Southwest Oncology Group Study.
    Alberts DS; Kronmal R; Baker LH; Stock-Novack DL; Surwit EA; Boutselis JG; Hannigan EV
    J Clin Oncol; 1987 Nov; 5(11):1791-5. PubMed ID: 2445932
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A phase II study of carboplatin and cisplatin in advanced or recurrent squamous carcinoma of the uterine cervix.
    Morris M; Gershenson DM; Burke TW; Mitchell MF; Levenback C; Atkinson N; Wharton JT
    Gynecol Oncol; 1994 May; 53(2):234-8. PubMed ID: 8188085
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phase II trial of paclitaxel and cisplatin in women with advanced breast cancer: an active regimen with limiting neurotoxicity.
    Wasserheit C; Frazein A; Oratz R; Sorich J; Downey A; Hochster H; Chachoua A; Wernz J; Zeleniuch-Jacquotte A; Blum R; Speyer J
    J Clin Oncol; 1996 Jul; 14(7):1993-9. PubMed ID: 8683229
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The activity of paclitaxel in gastrointestinal tumors.
    Ajani JA; Ilson DH; Kelsen DP
    Semin Oncol; 1995 Oct; 22(5 Suppl 12):46-50; discussion 51-3. PubMed ID: 7481861
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Paclitaxel by 24- or 1-hour infusion n combination with carboplatin in advanced non-small cell lung cancer: the Fox Chase Cancer Center experience.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Johnson S; Ozols RF
    Semin Oncol; 1995 Aug; 22(4 Suppl 9):18-29. PubMed ID: 7544025
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paclitaxel and carboplatin in combination in the treatment of advanced non-small-cell lung cancer: a phase II toxicity, response, and survival analysis.
    Langer CJ; Leighton JC; Comis RL; O'Dwyer PJ; McAleer CA; Bonjo CA; Engstrom PF; Litwin S; Ozols RF
    J Clin Oncol; 1995 Aug; 13(8):1860-70. PubMed ID: 7543559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase II evaluation of cisplatin and 5-fluorouracil in patients with advanced squamous cell carcinoma of the cervix: a Gynecologic Oncology Group Study.
    Bonomi P; Blessing J; Ball H; Hanjani P; DiSaia PJ
    Gynecol Oncol; 1989 Sep; 34(3):357-9. PubMed ID: 2767528
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Paclitaxel has moderate activity in squamous cervix cancer. A Gynecologic Oncology Group study.
    McGuire WP; Blessing JA; Moore D; Lentz SS; Photopulos G
    J Clin Oncol; 1996 Mar; 14(3):792-5. PubMed ID: 8622025
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A phase II study of ifosfamide, carboplatin and cisplatin in advanced and recurrent squamous cell carcinoma of the uterine cervix.
    Filtenborg TA; Hansen HH; Aage Engelholm S; Rørth M
    Ann Oncol; 1993 Jun; 4(6):485-8. PubMed ID: 8353091
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Randomized trial of three cisplatin dose schedules in squamous-cell carcinoma of the cervix: a Gynecologic Oncology Group study.
    Bonomi P; Blessing JA; Stehman FB; DiSaia PJ; Walton L; Major FJ
    J Clin Oncol; 1985 Aug; 3(8):1079-85. PubMed ID: 3894589
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Phase II trial of bleomycin, ifosfamide, and carboplatin in metastatic cervical cancer.
    Murad AM; Triginelli SA; Ribalta JC
    J Clin Oncol; 1994 Jan; 12(1):55-9. PubMed ID: 7505808
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phase II trial of paclitaxel in patients with progressive ovarian carcinoma after platinum-based chemotherapy: a Gynecologic Oncology Group study.
    Thigpen JT; Blessing JA; Ball H; Hummel SJ; Barrett RJ
    J Clin Oncol; 1994 Sep; 12(9):1748-53. PubMed ID: 7916038
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.